225 research outputs found
Bregman Graph Neural Network
Numerous recent research on graph neural networks (GNNs) has focused on
formulating GNN architectures as an optimization problem with the smoothness
assumption. However, in node classification tasks, the smoothing effect induced
by GNNs tends to assimilate representations and over-homogenize labels of
connected nodes, leading to adverse effects such as over-smoothing and
misclassification. In this paper, we propose a novel bilevel optimization
framework for GNNs inspired by the notion of Bregman distance. We demonstrate
that the GNN layer proposed accordingly can effectively mitigate the
over-smoothing issue by introducing a mechanism reminiscent of the "skip
connection". We validate our theoretical results through comprehensive
empirical studies in which Bregman-enhanced GNNs outperform their original
counterparts in both homophilic and heterophilic graphs. Furthermore, our
experiments also show that Bregman GNNs can produce more robust learning
accuracy even when the number of layers is high, suggesting the effectiveness
of the proposed method in alleviating the over-smoothing issue
Patients with myasthenia gravis with acute onset of dyspnea: predictors of progression to myasthenic crisis and prognosis
Background: Life-threatening myasthenic crisis (MC) occurs in 10–20% of the patients with myasthenia gravis (MG). It is important to identify the predictors of progression to MC and prognosis in the patients with MG with acute exacerbations.
Objective: This study aimed to explore the predictors of progression to MC in the patients with MG with acute onset of dyspnea and their short-term and long-term prognosis.
Methods: This study is a retrospective cohort study. We collected and analyzed data on all the patients with MG with acute dyspnea over a 10-year period in a single center using the univariate and multivariate analysis.
Results: Eighty-six patients with MG were included. In their first acute dyspnea episodes, 36 (41.9%) episodes eventually progressed to MC. A multivariate analysis showed that the early-onset MG (adjusted OR: 3.079, 95% CI 1.052–9.012) and respiratory infection as a trigger (adjusted OR: 3.926, 95% CI 1.141–13.510) were independent risk factors for the progression to MC, while intravenous immunoglobulin (IVIg) treatment prior to the mechanical ventilation (adjusted OR: 0.253, 95% CI 0.087–0.732) was a protective factor. The prognosis did not significantly differ between the patients with and without MC during the MG course, with a total of 45 (52.3%) patients reaching post-intervention status better than minimal manifestations at the last follow-up.
Conclusion: When treating the patients with MG with acute dyspnea, the clinicians should be aware of the risk factors of progression to MC, such as early-onset MG and respiratory infection. IVIg is an effective treatment. With proper immunosuppressive therapy, this group of patients had an overall good long-term prognosis
An Adaptive Framework of Geographical Group-Specific Network on O2O Recommendation
Online to offline recommendation strongly correlates with the user and
service's spatiotemporal information, therefore calling for a higher degree of
model personalization. The traditional methodology is based on a uniform model
structure trained by collected centralized data, which is unlikely to capture
all user patterns over different geographical areas or time periods. To tackle
this challenge, we propose a geographical group-specific modeling method called
GeoGrouse, which simultaneously studies the common knowledge as well as
group-specific knowledge of user preferences. An automatic grouping paradigm is
employed and verified based on users' geographical grouping indicators. Offline
and online experiments are conducted to verify the effectiveness of our
approach, and substantial business improvement is achieved.Comment: 7 pages, 4 figures, Accepted by ECIR 202
Feature selective temporal prediction of Alzheimer’s disease progression using hippocampus surface morphometry
IntroductionPrediction of Alzheimer’s disease (AD) progression based on baseline measures allows us to understand disease progression and has implications in decisions concerning treatment strategy. To this end, we combine a predictive multi‐task machine learning method (cFSGL) with a novel MR‐based multivariate morphometric surface map of the hippocampus (mTBM) to predict future cognitive scores of patients.MethodsPrevious work has shown that a multi‐task learning framework that performs prediction of all future time points simultaneously (cFSGL) can be used to encode both sparsity as well as temporal smoothness. The authors showed that this method is able to predict cognitive outcomes of ADNI subjects using FreeSurfer‐based baseline MRI features, MMSE score demographic information and ApoE status. Whilst volumetric information may hold generalized information on brain status, we hypothesized that hippocampus specific information may be more useful in predictive modeling of AD. To this end, we applied a multivariate tensor‐based parametric surface analysis method (mTBM) to extract features from the hippocampal surfaces.ResultsWe combined mTBM features with traditional surface features such as middle axis distance, the Jacobian determinant as well as 2 of the Jacobian principal eigenvalues to yield 7 normalized hippocampal surface maps of 300 points each. By combining these 7 × 300 = 2100 features together with the previous ~350 features, we illustrate how this type of sparsifying method can be applied to an entire surface map of the hippocampus that yields a feature space that is 2 orders of magnitude larger than what was previously attempted.ConclusionsBy combining the power of the cFSGL multi‐task machine learning framework with the addition of AD sensitive mTBM feature maps of the hippocampus surface, we are able to improve the predictive performance of ADAS cognitive scores 6, 12, 24, 36 and 48 months from baseline.In this work, we present our results of using machine learning to predict temporal behavior changes in Alzheimers Disease using entire topological feature maps of the hippocampus surface (2100 feature points). Our paper demonstrates that it is possible to use an entire topological map instead of just imaging derived volumetric measurements for predicting behavioral changes. We compare these results with previous results using only volumetric MR imaging features (309 features points) and show through repeated cross‐validation rounds that we are able to get better predictive power.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137757/1/brb3733_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/137757/2/brb3733.pd
Association between clinical factors and result of immune checkpoint inhibitor related myasthenia gravis: a single center experience and systematic review
Background: Neurological immune-related adverse events (nirAEs) are rare toxicities of immune-checkpoint inhibitors (ICI). With the increase use of ICIs, incidence of nirAEs is growing, among which ICI related MG (irMG) is causing high fatality rate. Given the limited evidence, data from a large cohort of patients with irMG is needed to aid in recognition and management of this fatal complication.
Objective: This study aimed to summarize clinical characteristics of irMG and explore predictors of irMG clinical outcome.
Methods: We summarized our institution's patients who were diagnosed as irMG between Sep 2019 and Oct 2021. We systematically reviewed the literature through Oct 2021 to identify all similar reported patients who met inclusion criteria. As the control group, patients with idiopathic MG were used. We collected data on clinical features, management, and outcomes of both irMG and idioMG cases. Further statistical analysis was conducted.
Results: Sixty three irMG patients and 380 idioMG patients were included in the final analysis. For irMG patients, six were from our institution while the rest 57 were from reported cases. The average age of irMG patients is 70.16 years old. Forty three were male. Average time from first ICI injection to symptom onset was 5.500 weeks. Eleven patients had a past history of MG. Higher MGFA classification and higher QMGS rates were observed in irMG patients compared to idioMG patients. For complication, more irMG patients had myositis or myocarditis overlapping compared to idioMG patients. The most commonly used treatment was corticosteroids for both idioMG and irMG. Twenty one patients (35%) with irMG had unfavorable disease outcome. Single variate and multivariate binary logistic regression proved that association with myocarditis, high MGFA classification or QMGS rates at first visit were negatively related to disease outcome in irMG patients.
Conclusion: irMG is a life-threatening adverse event. irMG has unique clinical manifestations and clinical outcome compared to idioMG. When suspicious, early evaluation of MGFA classification, QMGS rates and myositis/myocarditis evaluation are recommended
- …